BioStem Technologies, Inc. (BSEM) vs Dogwood Therapeutics, Inc. (DWTX)

A side-by-side comparison of BioStem Technologies, Inc. and Dogwood Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BSEM vs DWTX

growth of $100 · dividends reinvested · last 6y
BSEM +84.0% (+10.7%/yr)DWTX -99.6% (-60.8%/yr)BSEM compounded faster over this window
Log scale — wide-divergence pair
01101001k10kStart $100202120222023202420252026$184$0
BSEM DWTX

BSEM vs DWTX: by the numbers

  • •DWTX is the larger company ($52M vs $43M market cap).
  • •Both run net losses; DWTX's is the smaller (0.00% vs -13.86% net margin).

Metrics side by side

Valuation

MetricBSEMDWTX
P/B ratio1.570.77

Profitability

MetricBSEMDWTX
Gross margin93.13%0.00%
Operating margin-1.45%0.00%
Net margin-13.86%0.00%
ROE-102.45%-52.72%
ROIC-80.92%-38.04%

Growth (annualized)

MetricBSEMDWTX
Total return CAGR (5Y)15.72%-58.44%

Frequently asked

How have BSEM and DWTX total returns compared?
Over the past 5 years, BSEM delivered 15.72% and DWTX delivered -58.44% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.